CohBar

$0.8921
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0303 (-3.28%) As of 11:03 AM EDT today

Why Robinhood?

You can buy or sell CohBar and other stocks, options, and ETFs commission-free!

About CWBR

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. Read More The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA. The listed name for CWBR is CohBar, Inc. Common Stock.

Employees
13
Headquarters
Menlo Park, California
Founded
2007
Market Cap
51.71M
Price-Earnings Ratio
Dividend Yield
Average Volume
396.59K
High Today
$0.935
Low Today
$0.884
Open Price
$0.935
Volume
128.89K
52 Week High
$4.25
52 Week Low
$0.85

Collections

CWBR Earnings

-$0.10
-$0.07
-$0.03
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 5, After Hours

You May Also Like